Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer

Summary

In Western industrialized countries, endometrial cancer is the most common malignancy of the female reproductive tract. The general therapy options are surgery, radiotherapy, chemotherapy and endocrine therapy. This trial will investigate the efficacy and safety of letrozole in the treatment of advanced or recurrent hormone receptor-positive endometrial cancer .

Timeline

Start

2005-04

Primary completion

2010-05

Completion

—

Drugs

Indications